Pregnancy in patients with pulmonary arterial hypertension (PAH) is linked to several risks. Women of childbearing age are often encouraged to avoid pregnancy. But when pregnancy does occur, how can clinicians balance improvement of outcomes with considerations for the maternal and fetal health? Joining Dr. Charles Turck to discuss these issues and more is Dr. Evelyn Hermes-DeSantis, director of the Drug Information Service at Robert Wood Johnson University Hospital in New Brunswick, New Jersey, and clinical associate professor at the Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey.